Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Calibration × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Insulin Resistance 1

Interventions

Cisplatin 3176 Cyclophosphamide 3172 Carboplatin 2955 Radiotherapy 2771 Paclitaxel 2705 Gemcitabine 2549 pembrolizumab 2368 Bevacizumab 2192 Docetaxel 2190 Fluorouracil 1837 Capecitabine 1815 Oxaliplatin 1723 Dexamethasone 1592 Nivolumab 1575 Doxorubicin 1500 Rituximab 1480 Magnetic Resonance Spectroscopy 1365 Etoposide 1341 Irinotecan 1240 Leucovorin 1215 Drug Therapy 1189 Cytarabine 1126 Pemetrexed 1067 fludarabine 1035 Specimen Handling 985 Vincristine 964 Prednisone 940 Cetuximab 938 Trastuzumab 936 Lenalidomide 932

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07483723 2026-03-19

PROGLYSOPK

Centre Hospitalier Universitaire, Amiens

Phase NA Recruiting

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡